ReMash 80 Resmetirom Tablets

ReMash 80 Resmetirom Tablets

Therapeutic Class: HORMONES
Manufacturer:
Get Quote

ReMash 80 Resmetirom Tablets
Resmetirom is an oral, first, liver-directed, selective thyroid hormone receptor-beta (THR-β) agonist approved by US FDA for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).

It modulates lipid metabolism and reduces hepatic steatosis and inflammation without systemic thyromimetic effects.

Resmetirom is the first and only approved drug shown to significantly reverse fibrosis in patients with MASH.

Salt Composition: Resmetirom 80mg
Strength: Resmetirom 80mg
Pack Size: 30 tablets
Uses: Resmetirom is indicated along with diet and exercise for the treatment of non-cirrhotic MASH with moderate to advanced liver fibrosis (stage F2–F3)
Table Header
Salt Composition
Resmetirom 80mg
Strength
Resmetirom 80mg
Pack Size
30 tablets
Uses
Resmetirom is indicated along with diet and exercise for the treatment of non-cirrhotic MASH with moderate to advanced liver fibrosis (stage F2–F3)
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India. Product is supplied for Tenders/ Emergency imports/ Unlicensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Product names, logos, brands and other trademarks featured or referred to are the property of their respective Trademark Holders. The information provided here is for Informational purposes only.

Product information is meant for


WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories